Karima Salway

  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
Profile Experience

Karima Salway is an associate in the London office of Latham & Watkins, and is a member of the Corporate Department.

Ms. Salway's practice focuses on cross-border mergers and acquisitions and general corporate matters. She has worked on a wide range of sell-side and buy-side transactions across a variety of industries.

Ms. Salway has spent time on secondment at Morgan Stanley, where she sat and worked with the UK investment banking division on a range of corporate transactions and corporate advisory matters.

Ms. Salway's experience includes advising:

  • Duke Street, Wagamama management, and certain other shareholders in connection with the acquisition by The Restaurant Group plc of the Wagamama group
  • The founders of Dubizzle on the sale of their shareholdings in Dubizzle, the largest online classifieds platform in the Middle East
  • The sellers on the disposal by way of auction of the Method and Ecover global consumer products businesses to US private company SC Johnson
  • Theramex, a global specialty pharmaceutical company dedicated to women’s healthcare, in connection with the US$703 million acquisition by CVC Capital Partners of women’s healthcare assets from Teva Pharmaceutical Industries Ltd.
  • Coesia SpA in connection with the acquisition of the Instrumentation & Tobacco Machinery business of Molins, a manufacturer of secondary tobacco processing machinery
  • The Momondo Group in connection with the acquisition by the Priceline Group
  • Sienna Biopharmaceuticals in connection with its acquisition of Creabilis plc, a privately held specialty pharmaceutical company
  • Chinese-listed client Hytera Communications Corporation Limited in connection with its acquisition of London Stock Exchange listed digital radio products manufacturer Sepura Group PLC by way of a Takeover Code scheme of arrangement
  • Carbylan Therapeutics, Inc., a developer of clinical-stage specialty pharmaceutical treatments, in connection with the reverse merger of Carbylan Therapeutics with KalVista Pharmaceuticals
  • The Michelin Group on the acquisition of BookaTable, the online restaurant booking provider*
  • The founders of Lansdowne Chemicals plc on the sale of a chemical manufacturing and distribution company to Overlack AG*

*Matter handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.